Northeast Financial Consultants’s Gilead Sciences GILD Stock Holding History

Northeast Financial Consultants’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,590	Closed	-$268K	–	296
2020 Q1	$268K	Buy	3,590 +72	+2%	+$4.97K	0.03%	208
2019 Q4	$229K	Buy	3,518 +193	+6%	+$12.6K	0.02%	270
2019 Q3	$211K	Buy	3,325 +51	+2%	+$3.33K	0.02%	298
2019 Q2	$221K	Buy	+3,274	New	+$215K	0.02%	294
2016 Q2	–	Sell	-2,469	Closed	-$227K	–	153
2016 Q1	$227K	Hold	2,469	–	–	0.12%	119
2015 Q4	$250K	Hold	2,469	–	–	0.13%	105
2015 Q3	$242K	Hold	2,469	–	–	0.12%	112
2015 Q2	$289K	Buy	+2,469	New	+$270K	0.13%	117
2014 Q3	–	Sell	-3,469	Closed	-$287K	–	140
2014 Q2	$287K	Hold	3,469	–	–	0.16%	96
2014 Q1	$246K	Buy	+3,469	New	+$272K	0.14%	99

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northeast Financial Consultants's GILD Position: Q2 2020 in Review

Northeast Financial Consultants sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 3,590 shares — an estimated $268K sold.

Northeast Financial Consultants first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $289K in Q2 2015. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

Northeast Financial Consultants reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
Northeast Financial Consultants sold 3,590 Gilead Sciences shares in Q2 2020, an estimated $268K.
Northeast Financial Consultants first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Northeast Financial Consultants's Gilead Sciences position peaked at $289K in Q2 2015.
1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Northeast Financial Consultants's 13F filing for Q2 2020, filed 30 Jul 2020.